Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients
J Hypertens
.
2020 Jul;38(7):1386.
doi: 10.1097/HJH.0000000000002495.
Authors
Lorenzo A Calò
1
,
Paul A Davis
2
,
Matteo Rigato
1
,
Luca Sgarabotto
1
Affiliations
1
Department of Medicine, Nephrology, Dialysis and Transplantation Unit, University of Padova, Padova, Italy.
2
Department of Nutrition, University of California, Davis, California, USA.
PMID:
32502097
DOI:
10.1097/HJH.0000000000002495
No abstract available